Corrigendum to "A systematic review of higher-risk myelodysplastic syndromes clinical trials to determine the benchmark of azacitidine and explore alternative endpoints for overall survival" [Leukemia Res. 104 March (2021)].

Garcia, Jacqueline S; Swords, Ronan T; Roboz, Gail J; Jacoby, Meagan A; Garcia-Manero, Guillermo; Hong, Wan-Jen; Yang, Xiaoqing; Zhou, Ying; Platzbecker, Uwe; Steensma, David P; Wolff, Johannes E; Fenaux, Pierre

Garcia, Jacqueline S; Swords, Ronan T; Roboz, Gail J; Jacoby, Meagan A; Garcia-Manero, Guillermo; Hong, Wan-Jen; Yang, Xiaoqing; Zhou, Ying; Platzbecker, Uwe; Steensma, David P; Wolff, Johannes E; Fenaux, Pierre.

Affiliation

Garcia JS; Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: Jacqueline_garcia@dfci.harvard.edu.
Swords RT; AbbVie Inc., North Chicago, IL, USA.
Roboz GJ; Weill Medical College of Cornell University and New York-Presbyterian Hospital, NY, NY, USA.
Jacoby MA; Washington University School of Medicine, St. Louis, MO, USA.
Garcia-Manero G; University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA.
Hong WJ; Genentech Inc., South San Francisco, CA, USA.
Yang X; AbbVie Inc., North Chicago, IL, USA.
Zhou Y; AbbVie Inc., North Chicago, IL, USA.
Platzbecker U; Leipzig University Hospital, Leipzig, Germany.
Steensma DP; Dana-Farber Cancer Institute, Boston, MA, USA.
Wolff JE; AbbVie Inc., North Chicago, IL, USA.
Fenaux P; Hôpital Saint-Louis, Assistance Publique - Hôpitaux de Paris, Université de Paris, Paris, France.

Leuk Res ; 105: 106581, 2021 Jun.

Article in En | MEDLINE | ID: mdl-33896620

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Risk_factors_studies / Systematic_reviews Language: En Journal: Leuk Res Year: 2021 Document type: Article Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google